International Association for the Study of Lung Cancer shared on LinkedIn:
“This episode of Lung Cancer Considered in Cantonese focuses on the management of EGFR-mutant NSCLC.
Host Dr. Molly Li is joined by Dr. Rina Hui and Dr. Zhang Li for a Virtual Tumor Board discussion on diagnosis, treatment selection, multidisciplinary approaches, and considerations for patient follow-up.
More posts featuring IASLC.